Daniel Stachel
Overview
Explore the profile of Daniel Stachel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Green M, Leisenring W, Stachel D, Pergam S, Sandmaier B, Wald A, et al.
Biol Blood Marrow Transplant
. 2012 Jun;
18(11):1687-99.
PMID: 22683614
Cytomegalovirus (CMV) surveillance and preemptive therapy is the most commonly used strategy for CMV disease prevention in hematopoietic cell transplantation recipients. In 2007, we introduced a CMV prevention strategy for...
12.
Kreyenberg H, Jarisch A, Bayer C, Schuster B, Willasch A, Strahm B, et al.
Blood
. 2011 Jul;
118(4):1181-4.
PMID: 21799103
No abstract available.
13.
Naumann-Bartsch N, Stachel D, Morhart P, Staatz G, Jungert J, Schwarz K, et al.
Pediatrics
. 2009 Dec;
125(1):e169-73.
PMID: 20026502
Autoimmune lymphoproliferative syndrome (ALPS) is an uncommon disorder of Fas-mediated apoptosis that results in impaired lymphocyte death and, therefore, disturbed immune homeostasis. Besides presentation with lymphadenopathy and splenomegaly, patients with...
14.
Schmid I, Stachel D, Pagel P, Albert M
Biol Blood Marrow Transplant
. 2008 Mar;
14(4):438-44.
PMID: 18342786
Engraftment syndrome (ES) has been recognized as an inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation (HSCT) characterized by noninfectious fever and skin rash. It has been reported...
15.
Lehner M, Bailo M, Stachel D, Roesler W, Parolini O, Holter W
Leuk Res
. 2007 Jun;
31(12):1729-35.
PMID: 17572490
Pro-apoptotic signalling upon toll-like receptor (TLR) stimulation in myeloid cells is normally antagonized by the simultaneous activation of anti-apoptotic pathways. We have previously reported that IFN-alpha can sensitize human monocytes...
16.
Lehner M, Morhart P, Stilper A, Petermann D, Weller P, Stachel D, et al.
J Immunother
. 2007 Apr;
30(3):312-22.
PMID: 17414322
Recent findings have demonstrated the properties of cell migration and cytokine secretion to be mutually exclusive and linked them to different functional subpopulations of dendritic cells (DCs). We studied human...
17.
Stachel D, Albert M, Meilbeck R, Paulides M, Schmid I
Oncol Rep
. 2006 Dec;
17(1):147-52.
PMID: 17143492
Pathological angiogenesis is increasingly recognized to be an important feature of pathogenesis in solid tumors and also in leukemias. Specific blockers of angiogenesis are now being introduced into early clinical...
18.
Metzler M, Bruch J, Stachel D, Langer T, Borkhardt A, Harbott J, et al.
Leuk Res
. 2006 Jul;
31(4):553-7.
PMID: 16814860
Differentiation between reactive bone marrow suppression due to viral infection and early stages of leukemia can be difficult particularly in young infants. We report on a 2-month-old girl presenting with...
19.
Rauh M, Stachel D, Kuhlen M, Groschl M, Holter W, Rascher W
Clin Pharmacokinet
. 2006 Mar;
45(3):305-16.
PMID: 16509762
Background And Objective: Busulfan pharmacokinetic studies suggest that an individual dosing strategy may be necessary to optimise systemic exposure in order to decrease toxicity and improve outcome in haematopoietic stem...
20.
Paulides M, Stohr W, Bielack S, Jurgens H, Koscielniak E, Klingebiel T, et al.
Oncol Rep
. 2006 Feb;
15(3):687-91.
PMID: 16465431
Cancer therapy and supportive measures entail the risk of infection with hepatitis B (HBV), hepatitis C (HCV) or human immunodeficiency virus (HIV). The objective of this analysis was to establish...